André Akira Sueno Goldani, Gabriel Feitosa, Eduarda Vasconcelos Colchete, Cristhian Ferreira Falleiro, Cristine Weihrauch Pedro, Félix Henrique Paim Kessler, Thiago M Fidalgo, Lisia von Diemen
{"title":"Undertreatment of Wernicke encephalopathy in alcohol-related clinical contexts: a scoping review of diagnosis, thiamine regimens, and clinical management.","authors":"André Akira Sueno Goldani, Gabriel Feitosa, Eduarda Vasconcelos Colchete, Cristhian Ferreira Falleiro, Cristine Weihrauch Pedro, Félix Henrique Paim Kessler, Thiago M Fidalgo, Lisia von Diemen","doi":"10.1186/s13722-026-00687-x","DOIUrl":"10.1186/s13722-026-00687-x","url":null,"abstract":"<p><strong>Background: </strong>Wernicke encephalopathy (WE) is a potentially reversible neurological emergency that remains frequently missed and undertreated in patients with alcohol use disorder (AUD). Although thiamine is widely accepted as the cornerstone of prevention and treatment, diagnostic uncertainty, limited comparative evidence, and heterogeneous clinical recommendations contribute to substantial variability in real-world management. This scoping review aimed to map the available evidence on the diagnosis and clinical management of WE in patients with AUD or clinically significant alcohol use, with particular attention to practice variability, undertreatment, and clinically actionable gaps in care.</p><p><strong>Methods: </strong>We conducted a scoping review in accordance with PRISMA-ScR guidance. Electronic databases and trial registries were searched for studies addressing the diagnosis, prevention, or treatment of WE in populations with AUD or clinically significant alcohol use. Eligible sources included randomized controlled trials, observational studies, clinical audits, and implementation-focused reports. Data were charted and synthesized thematically.</p><p><strong>Results: </strong>A total of 26 studies were included. The evidence base was limited and heterogeneous. Only two randomized controlled trials evaluated thiamine regimens, and no consensus emerged regarding optimal dosing. Diagnostic criteria for WE varied widely across studies, with inconsistent use of formal criteria such as the Caine criteria. Across observational studies and prescribing audits, undertreatment was consistently reported, including delayed initiation of therapy and frequent use of oral thiamine in high-risk scenarios. Studies describing more protocolized and guideline-concordant care more often reported earlier treatment initiation and use of parenteral thiamine in suspected or confirmed cases.</p><p><strong>Conclusions: </strong>WE remains underrecognized and undertreated in AUD and clinically significant alcohol use. The mapped evidence suggests that diagnostic uncertainty, limited trial data, and inconsistent implementation of recommendations are associated with persistent variability in care. Although the optimal thiamine regimen remains unresolved, early recognition and appropriate parenteral treatment in high-risk or suspected cases represent actionable opportunities to reduce preventable neurological morbidity.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13681891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tara Carney, J Anitha Menon, Beatrice Chiyokoma, Kudakwashe Madzeke, Giuliana Sanchez, Kim Johnson, Mathias Basera, Aline Berweger, Laura Ruckstuhl, Sina Hansen, Lisa Hofer, Jennifer M Belus
{"title":"Protocol for a cluster randomized controlled trial among young people and their peers to reduce substance use and inequitable gender beliefs in Southern Africa.","authors":"Tara Carney, J Anitha Menon, Beatrice Chiyokoma, Kudakwashe Madzeke, Giuliana Sanchez, Kim Johnson, Mathias Basera, Aline Berweger, Laura Ruckstuhl, Sina Hansen, Lisa Hofer, Jennifer M Belus","doi":"10.1186/s13722-026-00718-7","DOIUrl":"10.1186/s13722-026-00718-7","url":null,"abstract":"<p><strong>Background and aims: </strong>Substance use and the internalization of traditional gender norms, or inequitable gender beliefs, are co-occurring risk behaviors for poorer health and well-being in young people in Southern Africa. Addressing the social and structural factors that reinforce substance use and inequitable gender beliefs, including peer influence and socioeconomic adversity, such as lack of education or employment, is necessary to support sustainable change in these behaviors. However, most existing interventions focus only on changing individual behavior. This study will therefore aim to address this limitation by testing the efficacy of an intervention to reduce substance use and promote equitable gender beliefs, delivered to peer groups and embedded within existing vocational training (VT) programs.</p><p><strong>Design: </strong>Two-arm cluster randomized controlled superiority trial with assessments at baseline, 12-week, and 24-week follow-up.</p><p><strong>Setting: </strong>Selected VT programs in Zambia, Zimbabwe, and South Africa.</p><p><strong>Participants: </strong>Sixty-six peer groups (N ~ 264 participants) will be recruited, comprised of an index case plus 2 to 5 peers aged 16-24 years old, who use substances together weekly, or binge drink at least monthly, and enrolled in eligible VT programs.</p><p><strong>Intervention and comparator: </strong>Peer groups will be randomly allocated [1:1] to receive either: (i) the standard VT program plus Peer Education for Gender Inclusion and Substance Use in Southern Africa (PEGISUS), an 8-session interactive intervention delivered by VT program staff to peer groups or (ii) standard of care (SOC), namely the standard VT program and a referral for substance use services.</p><p><strong>Measurements: </strong>The primary outcome is the between-group (PEGISUS vs. SOC) mean difference in change in the total substance use involvement score on the ASSIST (Alcohol, Smoking, and Substance Involvement Screening Test) from baseline to the 12-week follow-up. Secondary outcomes compare the between-group mean difference in (1) other substance use scales on the ASSIST and at other timepoints (i.e. 24-week follow-up) (2); change in gender equitable beliefs using the GEMS (Gender Equitable Men's Scale) from baseline to the 12-week and 24-week follow-up; and (3) VT program attendance and completion rates, employment status, and income earned at the 24-week follow-up.</p><p><strong>Comments: </strong>This will be the first known study in Southern Africa to assess the efficacy of an intervention that addresses substance use and gender equity beliefs among young people and their peers delivered in VT programs. PEGISUS will address socioeconomic adversity and offer a potential pathway to sustainable delivery by embedding the intervention within existing VT programs. If unhealthy risk behaviors are reduced, and employment opportunities are improved, this can lead to improved well-being in the li","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13663153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149185915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TaReva Warrick-Stone, Serge-Emile Simpson, Phil Durney, Dennis Goodstein, Catherine Abrams, Raymond Bobb, Kory London, Daniel Teixeira da Silva
{"title":"Responding to medetomidine in Philadelphia: narrative summary of the public health response to a new psychoactive substance.","authors":"TaReva Warrick-Stone, Serge-Emile Simpson, Phil Durney, Dennis Goodstein, Catherine Abrams, Raymond Bobb, Kory London, Daniel Teixeira da Silva","doi":"10.1186/s13722-026-00713-y","DOIUrl":"10.1186/s13722-026-00713-y","url":null,"abstract":"<p><strong>Background: </strong>Despite the emergence of medetomidine as the dominant adulterant in Philadelphia's illicit opioid supply, coordinated public health responses are limited or non-existent in the literature. Thus, we summarize a recent Summit in Philadelphia of outpatient and inpatient service providers who specialize in the care of persons who use drugs to discuss medetomidine response readiness and building ongoing community readiness for potential destabilizing drug supply changes.</p><p><strong>Purpose: </strong>Describe a public health intervention that distributed information about practices across health care settings and mobilized key informants to identify and address barriers to treatment.</p><p><strong>Methods: </strong>Descriptive summary of the in-person Summit organized by the Division of Substance Use Prevention and Harm Reduction at the Philadelphia Department of Public Health and the Health Federation of Philadelphia's Substance Use Response, Guidance, and Education program to review cases of medetomidine-associated withdrawal across outpatient, emergency department, hospital, and substance use treatment settings.</p><p><strong>Results: </strong>The authors reviewed the insights from attendees and grouped them into nine themes: overdose response, clinical recognition of withdrawal, monitoring withdrawal, treatment approach, patient care navigation, workforce development, testing and surveillance, mobile outreach, and reimbursement. The authors subsequently developed twelve summative recommendations to guide further public health interventions in Philadelphia and other communities where medetomidine may become a common adulterant in the drug supply.</p><p><strong>Conclusion: </strong>The insights gained regarding medetomidine withdrawal management will be shared with community organizations providing services to people who use drugs in Philadelphia and clarify specific barriers and areas for ongoing support. Other communities experiencing shifts in drug supply may benefit from this knowledge and similar information sharing colloquiums.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13528134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mia A Navarro, Theresa E Matson, Hélène Chokron Garneau, Briana M Patrick, Lia Chin-Purcell, Shubhi Sharma, Tyler D Barrett, Rebecca C Phillips, Joseph E Glass
{"title":"Designing a patient-centered care navigation intervention within a healthcare system for SUD care: a qualitative study.","authors":"Mia A Navarro, Theresa E Matson, Hélène Chokron Garneau, Briana M Patrick, Lia Chin-Purcell, Shubhi Sharma, Tyler D Barrett, Rebecca C Phillips, Joseph E Glass","doi":"10.1186/s13722-026-00712-z","DOIUrl":"10.1186/s13722-026-00712-z","url":null,"abstract":"<p><strong>Background: </strong>Healthcare systems often struggle to provide timely access to care for patients with substance use disorder, and many patients do not successfully engage with treatment. Care navigation interventions have emerged as a strategy to help patients navigate complex health systems, address barriers to care, and improve treatment initiation and engagement, but little information exists about how to optimize these interventions within health system settings. In preparation for the Addressing Barriers to Care for Substance Use Disorder Trial, a hybrid effectiveness-implementation study conducted in a large integrated healthcare system, we undertook a series of design activities including piloting, stakeholder engagement, and iterative process redesign. As part of this broader effort, this qualitative study elicited the perspectives of patients and clinicians on barriers and facilitators to substance use treatment and ways to optimize the implementation of care navigation within the healthcare system's mental health access center.</p><p><strong>Methods: </strong>We conducted semi-structured interviews with 21 patients who sought treatment for substance use disorder and eight clinicians working in the mental health access center who assessed and referred patients to treatment. Interview transcripts were analyzed using the Rapid Group Analysis Process method, a novel rapid qualitative analysis method, to identify crosscutting themes related to care navigation.</p><p><strong>Results: </strong>Analyses identified several crosscutting themes that conveyed ways that care navigators could help connect patients to substance use treatment: by communicating effectively with patients, by leveraging substance use disorder resources, by supporting patient motivation, and by addressing logistical barriers to treatment. These themes closely aligned with the study's existing care navigation protocol. Findings also informed several refinements to improve the fit of care navigation within the health system's existing workflows.</p><p><strong>Conclusions: </strong>Identification of crosscutting themes via qualitative interviews confirmed the relevance of care navigation to the study population and helped optimize the intervention within the healthcare system. This study provides an example of how to incorporate stakeholder perspectives during intervention development and early implementation, particularly when adapting evidence-based approaches for new populations and settings.</p><p><strong>Trial registration: </strong>The clinical trial referenced in this study was prospectively registered at www.</p><p><strong>Clinicaltrials: </strong>gov (NCT06729957) on December 9, 2024.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13757133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nina Jobling, Kristian Mjåland, Thomas Clausen, Anne Taraldsen Heldal, Birgitte Thylstrup, John-Kåre Vederhus
{"title":"Medication transitions and predictors of illicit substance use during opioid agonist treatment: a three-year follow-up study.","authors":"Nina Jobling, Kristian Mjåland, Thomas Clausen, Anne Taraldsen Heldal, Birgitte Thylstrup, John-Kåre Vederhus","doi":"10.1186/s13722-026-00711-0","DOIUrl":"10.1186/s13722-026-00711-0","url":null,"abstract":"<p><strong>Background: </strong>For opioid use disorder (OUD), pharmacological therapy using methadone or buprenorphine, plus psychosocial support, is the most effective opioid agonist treatment (OAT). Long-acting injectable buprenorphine (LAIB) is the newest buprenorphine formulation. This study evaluated LAIB within a naturalistic clinical setting, compared with standard OAT (sublingual buprenorphine and methadone).</p><p><strong>Methods: </strong>This observational study included patients from an OAT outpatient clinic in Agder County, Norway. Data were extracted from hospital medical records in May 2022. The cohort was followed up in February 2025. Medication-group transitions and outcomes were assessed by examining switching, discontinuation, mortality, and illicit substance use over three years.</p><p><strong>Results: </strong>The study included 424 patients. The LAIB group was significantly younger than the standard OAT groups. During the study period, 13.2% of patients switched medications, increasing the LAIB group from 17% to 22%. Comparable proportions of patients experienced negative outcomes: 10% discontinued treatment, and 4% died. At follow‑up, illicit substance-use problems were less frequent in the sublingual buprenorphine group than the other groups, a finding that appears to have been influenced by differential attrition. Baseline substance use was the strongest predictor of illicit substance use at follow‑up.</p><p><strong>Conclusions: </strong>The LAIB group slightly increased during the study period. Transitions between medication groups appeared to yield better substance-use outcomes at follow-up in the sublingual buprenorphine group, compared to in other groups. Baseline substance use was the strongest predictor of illicit use at follow‑up, suggesting that individual clinical characteristics may contribute more to outcomes than the specific medication pathway.</p><p><strong>Trial registration: </strong>Clinical trial: number not applicable.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13474765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148763816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multidisciplinary perspectives on a new hospital addiction consult service: a mixed-methods study.","authors":"M Holliday Davis, Jessica Tolbert, Sarah Nessen, Amanda Perez, Korey Henderson, Bridget Durkin, Judy Chertok, Jeanmarie Perrone, Rachel French, Rachel McFadden, Ashish Thakrar, Samantha Huo, J Deanna Wilson, Shoshana Aronowitz, Margaret Lowenstein","doi":"10.1186/s13722-026-00709-8","DOIUrl":"10.1186/s13722-026-00709-8","url":null,"abstract":"<p><strong>Background: </strong>Hospital-based Addiction Consult Services (ACS) are increasingly implemented to improve care for patients with substance use disorders (SUD). While ACS are generally well-regarded, healthcare professionals of various roles may hold different perceptions of their impact.</p><p><strong>Methods: </strong>We conducted a web-based survey of physicians, advanced practice providers (APP), and nurses at a Philadelphia academic hospital from August-September 2024, 16 to 17 months after ACS implementation. The survey assessed attitudes and perceptions of the ACS with 6 questions using a 5-point Likert scale. These data were integrated with results from semi-structured interviews with physicians, advanced practice providers (APPs), and nurses from November 2023-January 2024, 7-9 months after ACS implementation, to provide a richer understanding of provider perspectives on the impact of the ACS. We used descriptive statistics to characterize the samples and analyzed survey data by healthcare professional group chi-squared tests. Interviews were analyzed using thematic content analysis.</p><p><strong>Results: </strong>Of 793 healthcare professionals surveyed, 311 responded (39%), including 128 nurses (41%), 108 resident physicians (35%), 49 attending physicians (16%), and 26 APPs (8%). Most providers reported that the ACS positively impacted patient care. Significantly fewer nurses reported perceived improvements in quality of care and communication compared to other healthcare professionals (43-63% nurses vs. 77-98% other healthcare professionals, p < 0.001, for 5 of 6 questions). While qualitative feedback was positive across groups, nursing interview narratives emphasized communication gaps, limited integration between nursing and the ACS, and a desire for additional training and education around SUD care.</p><p><strong>Conclusions: </strong>While most providers reported positive impacts of the Addiction Consult Service, nurses perceived fewer benefits than physicians and advanced practice providers. Qualitative findings suggest these differences stem from communication gaps, limited integration of nursing into ACS workflows, and barriers to SUD education. Implementation strategies that strengthen communication with bedside nurses and expand structured SUD education may improve multidisciplinary engagement and maximize the impact of ACS models.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13749937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149388669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ava Abramowich, Piper Dickhout, Seonaid Nolan, Cameron R Eekhoudt, Sidney Roberge, Travis De Wolfe, Erika Mundel, Renée M Janssen, Andrea Ryan, Cheyenne Johnson, Laurel Lemchuk-Favel, Harmony Johnson, Jeanette M Bowles, Brittany B Dennis
{"title":"Implementing a new model of substance use care in British Columbia: healthcare staff experiences from the road to recovery initiative.","authors":"Ava Abramowich, Piper Dickhout, Seonaid Nolan, Cameron R Eekhoudt, Sidney Roberge, Travis De Wolfe, Erika Mundel, Renée M Janssen, Andrea Ryan, Cheyenne Johnson, Laurel Lemchuk-Favel, Harmony Johnson, Jeanette M Bowles, Brittany B Dennis","doi":"10.1186/s13722-026-00705-y","DOIUrl":"10.1186/s13722-026-00705-y","url":null,"abstract":"<p><strong>Background: </strong>To address the increasingly potent unregulated drug supply and the complex withdrawal syndromes that accompany it, a hospital-based withdrawal management unit was launched in September 2023 as part of Vancouver, Canada's Road to Recovery (R2R) initiative. This study explores healthcare staff experiences working within the new unit to identify opportunities to improve clinical service delivery and working conditions.</p><p><strong>Methods: </strong>This study employed a mixed method design. Between May and July 2024, R2R healthcare staff were invited to complete a cross-sectional survey to characterize their experiences working in a new hospital-based withdrawal management unit. A purposive sample of healthcare staff were selected to complete a one-time semi-structured qualitative interview between July and August 2024. Descriptive statistics were used to summarize survey data, while conventional content analysis was used to analyze qualitative data.</p><p><strong>Results: </strong>Thirty-three healthcare staff completed the study's cross-sectional survey, including clinicians (e.g., nurses, physicians, pharmacists) and other staff such as social workers, peer support specialists, and Indigenous Wellness Liaisons (IWLs). Overall, 97% (n = 32) reported feeling satisfied with their role at R2R. Most respondents felt the model of care was well-rounded (82%, n = 27), trauma-informed (82%, n = 27), culturally and spiritually sensitive (85%, n = 28), and safe (94%, n = 31). Qualitative interviews (n = 8) revealed a consistent sense of pride in delivering 'recovery-oriented' care. Participants also felt R2R care provision was individualized, high-quality, and promoted meaningful engagement with patients through the cultivation of a safe environment. Job satisfaction was linked with feeling autonomous in providing patients access to a comprehensive spectrum of substance use services. Integration of traditional healing practices, as well as the incorporation of unique provider roles including peer support specialists and IWLs were identified as unique factors contributing to positive work experiences. Areas identified to be challenges included overly rigid approaches to patient care following relapses to substance use, as well as ongoing shortages of experienced, culturally safe healthcare staff, contributing to capacity constraints and burnout in the midst of the ongoing toxic drug crisis.</p><p><strong>Conclusions: </strong>Overall, healthcare staff reported job satisfaction working in a new hospital-based withdrawal management unit. Furthermore, participants described the R2R model of care as comprehensive, trauma-informed, and culturally safe.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13737656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149335993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Conley Combs, Alexa B D'Angelo, Kira Argenio, Drew A Westmoreland, Raymond L Moody, Adam W Carrico, Christian Grov
{"title":"Insights for the substance use disorder care continuum: findings from a qualitative study with sexual and gender minority individuals who use methamphetamine.","authors":"Conley Combs, Alexa B D'Angelo, Kira Argenio, Drew A Westmoreland, Raymond L Moody, Adam W Carrico, Christian Grov","doi":"10.1186/s13722-026-00710-1","DOIUrl":"10.1186/s13722-026-00710-1","url":null,"abstract":"<p><strong>Background: </strong>Methamphetamine use continues to disproportionately affect sexual and gender minority (SGM) communities and is associated with physical, mental, and sexual health harms, including heightened HIV vulnerability. While prior epidemic waves have been well documented, the current resurgence (particularly among SGM individuals), remains underexplored and occurs within an evolving HIV prevention landscape. Persistent challenges within the substance use disorder care continuum (SUDCC), including stigma and limited treatment responsiveness, underscore the need for patient-centered clinical guidance. This study examines treatment navigation experiences of SGM individuals who use methamphetamine and their recommendations for improving their substance use care.</p><p><strong>Methods: </strong>Participants were recruited from a U.S. national HIV prevention cohort that oversampled for individuals reporting recent methamphetamine use. Twenty-nine participants completed semi-structured, in-depth interviews between December 2024 and January 2025. Interviews focused on healthcare experiences, treatment navigation, and participants' recommendations for SUDCC stakeholders. Interviews were recorded and transcribed verbatim into written transcripts, which were analyzed using a codebook approach to thematic analysis.</p><p><strong>Results: </strong>Our findings were organized into four major themes: (1) Variation in Motivation to Use Meth, (2) Need for Destigmatized Care, (3) Desire for SGM-Affirming Care, and (4) A Spectrum of Care Needs. Participants reported a variety of motivations for using meth, including to enhance their sex lives, cognition, and emotion regulation-motivations that providers may benefit from understanding as they aim to address the overlapping physical and psychosocial health needs of patients who use methamphetamine. The importance of reducing stigma in clinical encounters was underscored frequently by participants, and represented a salient theme throughout interviews and across thematic categories. Participants described both experienced and anticipated stigma when underscoring the need for de-stigmatized substance use care, and illustrated how stigma hindered substance use care engagement and use of emergency services. Moreover, many reported a desire for community among other SGM individuals, particularly within group recovery contexts, but also elucidated the risks that accompanied drug network expansion within these treatment environments.</p><p><strong>Conclusion: </strong>This study advances the substance use and treatment literature by amplifying the voices of SGM individuals who use methamphetamine and providing guidance for providers who work directly with these populations.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13729580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149327393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Art therapy in addiction recovery the face of addiction through artworks based on clinical case studies.","authors":"Petra Arnold, Máté Kapitány-Fövény","doi":"10.1186/s13722-026-00706-x","DOIUrl":"10.1186/s13722-026-00706-x","url":null,"abstract":"<p><p>Given the multifaceted nature of addiction, a multidisciplinary and comprehensive therapeutic approach is essential. Art therapy has therefore become an important complementary intervention in both inpatient and outpatient treatment settings. Numerous studies support its applicability and effectiveness among individuals with addiction. Art therapy can be particularly beneficial in reducing pervasive feelings of shame and anxiety, as well as in facilitating the processing of traumatic experiences - phenomena that are common among people with substance use disorder (SUD) and are often difficult to articulate verbally. The study examines the use of art therapy with clients with SUD, with a specific focus on the therapeutic factors that emerge through clinical practice. The analysis is grounded in three interrelated theoretical frameworks that help explain potential mechanisms of change in art therapy: trauma theory, mentalization-based approaches, and neurobiological and reward-related models. The case studies draw on two closed art therapy groups, consisting of 8 and 12 sessions respectively, at a drug outpatient treatment centre. Each group comprised eight adult participants with SUD. Most participants presented with comorbid conditions. Findings from the case studies suggest that the therapeutic factors associated with art therapy play a meaningful role in clients' recovery processes. Evidence of recovery is reflected in the artworks produced during therapy, which offer insight into clients' personalities, emerging behavioural and emotional patterns, and ongoing personal transformation. These visual expressions reflect clients' current level of self-awareness and may highlight obstacles that may hinder recovery. In this way, the artworks function as visual narratives that both document and support the therapeutic process. The findings provide practical implications for clinicians seeking to integrate art therapy into addiction treatment. They also contribute to a deeper understanding of the therapeutic potential of the arts in supporting recovery among individuals with SUD. Given the high prevalence of comorbid personality disorders and trauma histories among individuals with SUD, art therapy serves as a uniquely adaptable modality that complements both verbal psychotherapy and pharmacological interventions. Art therapy is also a valuable tool for status assessment, offering insight into personality traits and emotional states.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13422313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148632947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kelly W Gagnon, Margaret Baldwin, Yahya Alnashri, Jessica Jaiswal, Karen Cropsey, Ellen Eaton
{"title":"Measures of recovery used in clinical settings among people with opioid use disorder: a rapid review of the literature.","authors":"Kelly W Gagnon, Margaret Baldwin, Yahya Alnashri, Jessica Jaiswal, Karen Cropsey, Ellen Eaton","doi":"10.1186/s13722-026-00700-3","DOIUrl":"10.1186/s13722-026-00700-3","url":null,"abstract":"<p><strong>Background: </strong>The United States (US) has observed increasing rates of opioid use and overdose deaths since the 1990s. For patients receiving medications for opioid use disorder (OUD), clinical visits are a critical touchpoint to evaluate progress towards recovery.</p><p><strong>Objective: </strong>This rapid review aims to identify psychometrically validated measures of recovery used in clinical settings in the US for individuals with OUD.</p><p><strong>Methods: </strong>A systematic search of Embase and Health and Psychosocial Instruments databases was conducted.</p><p><strong>Inclusion criteria: </strong>peer-reviewed studies in English from 2000 to 2023 that applied recovery measures within U.S. clinical treatment settings for individuals with OUD. References were screening and data extracted using Rayyan. Identified measures were mapped to patient-centered treatment goals.</p><p><strong>Results: </strong>19 studies met the inclusion criteria, including 37 validated measures of recovery. Measures were predominantly designed to be self-administrated. Measures fell under three domains: exclusively measuring drug use, measuring drug use and other factors, and exclusively measuring factors other than drug use. The most used measure was the Addiction Severity Index, used in 10 studies. After mapping to established patient-centered treatment goals, avoid illicit drug use (n = 14, 38%) was the construct identified most frequently across included measures.</p><p><strong>Conclusion: </strong>This rapid review of OUD recovery measures found a wide range of measures used over the study period. The most used measures focused on frequency and severity of drug use. Patient-centered treatment goals were largely covered by identified measures. Self-administer design of most measures presents opportunity to leverage patient-reported outcomes in clinical settings to evaluate recovery and inform treatment plans. Future research should explore how customizable PROMs and PREMs for patients in treatment for OUD can support goal tracking, improve patient-clinician decision-making, and help patients with recovery.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"21 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13711745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}